Listeria monocytogenes strain-specific impairment of the tetr regulator underlies the drastic increase in cyclic di-AMP secretion and beta interferon-inducing ability

Infection and Immunity

Volumn 80, Issue 7, 2012, Pages 2323-2332

  Yamamoto, Takeshi ^a   Hara, Hideki ^a   Tsuchiya, Kohsuke ^a   Sakai, Shunsuke ^a   Fang, Rendong ^a   Matsuura, Motohiro ^a   Nomura, Takamasa ^b   Sato, Fumihiko ^c   Mitsuyama, Masao ^a   Kawamura, Ikuo ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JIN AI UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE PHOSPHATE; BETA INTERFERON; CYCLIC AMP;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; FEMALE; GENE CONTROL; GENE DELETION; GENE OVEREXPRESSION; GENETIC DISORDER; LISTERIA MONOCYTOGENES; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION;

ANIMALS; DINUCLEOSIDE PHOSPHATES; DNA, BACTERIAL; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; HOST-PATHOGEN INTERACTIONS; INTERFERON-BETA; LISTERIA MONOCYTOGENES; MACROPHAGES; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; REPRESSOR PROTEINS; SEQUENCE ANALYSIS, DNA; SEQUENCE DELETION;

EID: 84864810454     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.06162-11     Document Type: Article

References (54)

1. Akira S, Takeda K. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4:499-511.
2. Auerbuch V, Brockstedt DG, Meyer-Morse N, O'Riordan M, Portnoy DA. 2004. Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes. J. Exp. Med. 200:527-533.
3. Bortolussi R. 2008. Listeriosis: a primer. Can. Med. Assoc. J. 179:795-797.
4. Carrero JA, Calderon B, Unanue ER. 2004. Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection. J. Exp. Med. 200:535-540.
5. Chen W, Kuolee R, Yan H. 2010. The potential of 3', 5'-cyclic diguanylic acid (c-di-GMP) as an effective vaccine adjuvant. Vaccine 28:3080-3085.
6. Crimmins GT, et al. 2008. Listeria monocytogenes multidrug resistance transporters activate a cytosolic surveillance pathway of innate immunity. Proc. Natl. Acad. Sci. U. S. A. 105:10191-10196.
7. Decker T, Müller M, Stockinger S. 2005. The yin and yang of type I interferon activity in bacterial infection. Nat. Rev. Immunol. 5:675- 687.
8. Doganay M. 2003. Listeriosis: clinical presentation. FEMS Immunol. Med. Microbiol. 35:173-175.
9. Flannagan RS, Cosío G, Grinstein S. 2009. Antimicrobial mechanisms of phagocytes and bacterial evasion strategies. Nat. Rev. Microbiol. 7:355- 366.
10. Flo TH, et al. 2000. Human Toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide. J. Immunol. 164:2064-2069.
11. Fluman N, Bibi E. 2009. Bacterial multidrug transport through the lens of the major facilitator superfamily. Biochim. Biophys. Acta 1794:738-747.
12. Gomelsky M. 2011. cAMP, c-di-GMP, c-di-AMP and now cGMP: bacteria use them all! Mol. Microbiol. 79:562-565.
13. Hara H, et al. 2007. Cytolysin-dependent escape of the bacterium from the phagosome is required but not sufficient for induction of the Th1 immune response against Listeria monocytogenes infection: distinct role of listeriolysin O determined by cytolysin gene replacement. Infect. Immun. 75:3791-3801.
14. Hara H, et al. 2008. Dependency of caspase-1 activation induced in macrophages by Listeria monocytogenes on cytolysin, listeriolysin O, after evasion from phagosome into the cytoplasm. J. Immunol. 180:7859- 7868.
15. Hirakata Y, et al. 2009. Efflux pump inhibitors reduce the invasiveness of Pseudomonas aeruginosa. Int. J. Antimicrob. Agents 34:343-346.
16. Hirakata Y, et al. 2002. Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa. J. Exp. Med. 196:109-118.
17. Ishii KJ, et al. 2006. A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat. Immunol. 7:40-48.
18. Ishikawa H, Barber GN. 2008. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455:674-678.
19. Kanneganti TD, Lamkanfi M, Núñez G. 2007. Intracellular NOD-like receptors in host defense and disease. Immunity 27:549-559.
20. Kawai T, et al. 2005. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6:981-988.
21. Kim YG, et al. 2008. The cytosolic sensors Nod1 and Nod2 are critical for bacterial recognition and host defense after exposure to Toll-like receptor ligands. Immunity 28:246-257.
22. Mata MT, Baquero F, Pérez-Díaz JC. 2000. A multidrug efflux transporter in Listeria monocytogenes. FEMS Microbiol. Lett. 187:185-188.
23. McWhirter SM, et al. 2009. A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMP. J. Exp. Med. 206:1899-1911.
24. O'Connell RM, et al. 2004. Type I interferon production enhances susceptibility to Listeria monocytogenes infection. J. Exp. Med. 200:437- 445.
25. O'Connell RM, et al. 2005. Immune activation of type I IFNs by Listeria monocytogenes occurs independently of TLR4, TLR2, and receptor interacting protein 2 but involves TNFR-associated NF kappa B kinase-binding kinase 1. J. Immunol. 174:1602-1607.
26. O'Riordan M, Yi CH, Gonzales R, Lee KD, Portnoy DA. 2002. Innate recognition of bacteria by a macrophage cytosolic surveillance pathway. Proc. Natl. Acad. Sci. U. S. A. 99:13861-13866.
27. Park JM, Ng VH, Maeda S, Rest RF, Karin M. 2004. Anthrolysin O and other gram-positive cytolysins are Toll-like receptor 4 agonists. J. Exp. Med. 20:1647-1655.
28. Piddock LJ. 2006. Multidrug-resistance efflux pumps-not just for resistance. Nat. Rev. Microbiol. 4:629-636.
29. Portnoy DA, Auerbuch V, Glomski IJ. 2002. The cell biology of Listeria monocytogenes infection: the intersection of bacterial pathogenesis and cell-mediated immunity. J. Cell Biol. 158:409-414.
30. Portnoy DA, Jacks PS, Hinrichs DJ. 1988. Role of hemolysin for the intracellular growth of Listeria monocytogenes. J. Exp. Med. 1:1459-1471.
31. Rayamajhi M, Humann J, Penheiter K, Andreasen K, Lenz LL. 2010. Induction of IFN-alphabeta enables Listeria monocytogenes to suppress macrophage activation by IFN-gamma. J. Exp. Med. 207:327-337.
32. Reutterer B, et al. 2008. Type I IFN are host modulators of strain-specific Listeria monocytogenes virulence. Cell. Microbiol. 10:1116-1129.
33. Romanova NA, Wolffs PF, Brovko LY, Griffiths MW. 2006. Role of efflux pumps in adaptation and resistance of Listeria monocytogenes to benzalkonium chloride. Appl. Environ. Microbiol. 72:3298-3503.
34. Ryjenkov DA, Tarutina M, Moskvin OV, Gomelsky M. 2005. Cyclic diguanylate is a ubiquitous signaling molecule in bacteria: insights into biochemistry of the GGDEF protein domain. J. Bacteriol. 187:1792-1798.
35. Sauer JD, et al. 2011. The N-ethyl-N-nitrosourea-induced Goldenticket mouse mutant reveals an essential function of Sting in the in vivo interferon response to Listeria monocytogenes and cyclic dinucleotides. Infect. Immun. 79:688-694.
36. Sauer JD, et al. 2010. Listeria monocytogenes triggers AIM2-mediated pyroptosis upon infrequent bacteriolysis in the macrophage cytosol. Cell Host Microbe 7:412- 419.
37. Schlee M, et al. 2009. Approaching the RNA ligand for RIG-I? Immunol. Rev. 227:66-74.
38. Seki E, et al. 2002. Critical roles of myeloid differentiation factor 88-dependent proinflammatory cytokine release in early phase clearance of Listeria monocytogenes in mice. J. Immunol. 169:3863-3868.
39. Servant MJ, et al. 2001. Identification of distinct signaling pathways leading to the phosphorylation of interferon regulatory factor 3. J. Biol. Chem. 276:355-363.
40. Seveau S, Pizarro-Cerda J, Cossart P. 2007. Molecular mechanisms exploited by Listeria monocytogenes during host cell invasion. Microbes Infect. 9:1167-1175.
41. Siegman-Igra Y, et al. 2002. Listeria monocytogenes infection in Israel and review of cases worldwide. Emerg. Infect. Dis. 8:305-310.
42. Soulat D, Bauch A, Stockinger S, Superti-Furga G, Decker T. 2006. Cytoplasmic Listeria monocytogenes stimulates IFN-beta synthesis without requiring the adapter protein MAVS. FEBS Lett. 580:2341-2346.
43. Southwick FS, Purich DL. 1996. Intracellular pathogenesis of listeriosis. N. Engl. J. Med. 334:770-776.
44. Stetson DB, Medzhitov R. 2006. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 24:93-103.
45. Stockinger S, Decker T. 2008. Novel functions of type I interferons revealed by infection studies with Listeria monocytogenes. Immunobiology 213:889-897.
46. Stockinger S, et al. 2002. Production of type I IFN sensitizes macrophages to cell death induced by Listeria monocytogenes. J. Immunol. 169:6522- 6529.
47. Stockinger S, et al. 2004. IFN regulatory factor 3-dependent induction of type I IFNs by intracellular bacteria is mediated by a TLR- and Nod2-independent mechanism. J. Immunol. 173:7416-7425.
48. Sun Q, et al. 2006. The specific and essential role of MAVS in antiviral innate immune responses. Immunity 24:633- 642.
49. Takaoka A, Yanai H. 2006. Interferon signalling network in innate defence. Cell. Microbiol. 8:907-922.
50. Torres D, et al. 2004. Toll-like receptor 2 is required for optimal control of Listeria monocytogenes infection. Infect. Immun. 72:2131-2139.
51. Tsuchiya K, et al. 2010. Involvement of absent in melanoma 2 in inflammasome activation in macrophages infected with Listeria monocytogenes. J. Immunol. 185:1186-1195.
52. Warren SE, et al. 2010. Cytosolic bacterial DNA activates the inflammasome via Aim2. J. Immunol. 185:818-821.
53. Woodward JJ, Iavarone AT, Portnoy DA. 2010. c-di-AMP secreted by intracellular Listeria monocytogenes activates a host type I interferon response. Science 328:1703-1705.
54. Zhang B, et al. 2009. The TAK1-JNK cascade is required for IRF3 function in the innate immune response. Cell Res. 19:412- 428.